Randomised clinical trial to evaluate ACUITY bleeding rates in ST elevation myocardial infarction (STEMI) patients undergoing rescue percutaneous coronary intervention (PCI) post failed fibrinolysis, treated with bivalirudin or heparin and a glycoprotein IIb/IIIa inhibitor

Trial Profile

Randomised clinical trial to evaluate ACUITY bleeding rates in ST elevation myocardial infarction (STEMI) patients undergoing rescue percutaneous coronary intervention (PCI) post failed fibrinolysis, treated with bivalirudin or heparin and a glycoprotein IIb/IIIa inhibitor

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Bivalirudin (Primary) ; Abciximab; Eptifibatide; Heparin; Tirofiban
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Adverse reactions
  • Acronyms RESCUE-PCI
  • Most Recent Events

    • 08 Jun 2016 Status changed from not yet recruiting to completed.
    • 25 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top